TNM staging system

From WikiMD's Medical Encyclopedia

(Redirected from TNM classification)

TNM staging system is a globally recognized system for classifying the extent of spread of cancer. It is a tool used by oncologists to determine the prognosis and treatment plan for individuals diagnosed with cancer. The system is maintained by the Union for International Cancer Control (UICC).

Overview[edit]

The TNM staging system is based on the size and extent of the tumor (T), the number of nearby lymph nodes that have cancer (N), and whether the cancer has spread, or metastasized, to other parts of the body (M). Each of these categories is further divided into subcategories to provide a detailed description of the cancer's progression.

Components[edit]

Tumor (T)[edit]

The T in TNM stands for tumor. The size and extent of the primary tumor is classified on a scale from TX (tumor cannot be measured) to T4 (tumor has grown into nearby tissues or organs).

Nodes (N)[edit]

The N in TNM stands for nodes. This refers to whether the cancer has spread to nearby lymph nodes. It is classified on a scale from NX (cancer in nearby nodes cannot be measured) to N3 (cancer has spread to many nearby nodes).

Metastasis (M)[edit]

The M in TNM stands for metastasis. This refers to whether the cancer has spread to other parts of the body. It is classified as either M0 (no distant spread) or M1 (cancer has spread to distant parts of the body).

Usage[edit]

The TNM staging system is used by medical professionals worldwide to classify the extent of cancer spread. It helps in determining the prognosis and in planning the treatment. It also allows for the comparison of individual patient outcomes, both within and across institutions.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia

TNM staging system[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.